Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2008 058 421.6 |
96 | EP file number | EAKZ | 12 17 6584.6 |
97 | EP publication number | EPN | 2514740 |
54 | Designation/title | TI | DEUTERIERTE O-DESMETHYLVENLAFAXINE MIT SEROTONINERGISCHER UND/ODER NOREPINEPHRINERGISCHER AKTIVITÄT |
51 | IPC main class | ICM (ICMV) | C07C 217/74 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07C 215/64 (2006.01), C07D 265/16 (2006.01), C07B 59/00 (2006.01) |
22 | DE application date | DAT | Mar 13, 2008 |
96 | EP application date | EAT | Mar 13, 2008 |
43 | Date of first publication | OT | Oct 24, 2012 |
| Date of publication of grant | PET | Dec 19, 2018 |
71/73 | Applicant/owner | INH | Acadia Pharmaceuticals Inc., San Diego, CA, US |
72 | Inventor | IN | Gant, Thomas G, Vista, CA California 92081-8356, US; Sepher, Sarshar, Vista, CA California 92081-8356, US; Woo, Soon Hyung, Vista, CA California 92081-8356, US |
| Address for service | | RWS Group, Translation Division, Chalfont St Peter, Bucks SL9 9FGP, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 944399 P Jun 15, 2007
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 895049 P Mar 15, 2007
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002514740 Searchable text:
EP000002514740 Original document:
EP000002514740B1 Searchable text:
EP000002514740B1 |
43 | Date of first publication | EVT | Oct 24, 2012 |
| Date of the first transfer into DPMAregister | EREGT | Dec 7, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Dec 28, 2023 (Show all update days)(Hide all update days)- Dec 7, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Sep 30, 2021 |
| Issue number | HN | 45 |
| Year | PJ | 2021 |
| Publication date | VT | Nov 11, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Acadia Pharmaceuticals Inc., San Diego, CA, US |
71/73 | Previous applicant/owner | INHF | Auspex Pharmaceuticals, Inc., Vista, Calif., US |
| Date of update of the procedure | REGT | Nov 11, 2021 |